Guglielmo Vetere

11PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 13, 2026
Circulating Tumor DNA Dynamics in Patients with Liver-Limited Metastatic Colorectal Cancer Resected after First-Line Systemic Treatment.

Roberto Moretto, Vittorio Studiale, Seung Won Hyun

|Jan 08, 2025
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF -mutated metastatic colorectal cancer treated with targeted therapy.

Guglielmo Vetere, Marco Maria Germani, Carlotta Antoniotti

|Nov 07, 2024
KRASG12D-Mutated Metastatic Colorectal Cancer: Clinical, Molecular, Immunologic, and Prognostic Features of a New Emerging Targeted Alteration.

Roberto Moretto, Daniele Rossini, Sabina Murgioni

|Nov 06, 2024
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden.

Leonardo Provenzano, Yong Xiang Gwee, Veronica Conca

|Jul 29, 2024
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence.

Francesca Salani, Guglielmo Vetere, Daniele Rossini

|Feb 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Somaieh Hedayat, Luciano Cascione, David Cunningham

Pageof 2

Frequent Collaborators

7 joint publications

Chiara Cremolini

7 joint publications

Filippo Pietrantonio

6 joint publications

Sara Lonardi

3 joint publications

Alessandro Passardi